dow-jones
Alight Is Maintained at Buy by DA Davidson
Alight Is Maintained at Buy by DA Davidson
dow-jones
Pyxis Oncology Is Maintained at Outperform by Leerink Partners
(12:45 GMT) Pyxis Oncology Price Target Cut to $7.00/Share From $9.00 by Leerink Partners
NEWS dow-jones
Treasury Yields Drop After Jobs Data — WSJ
By Sam GoldfarbTreasury yields have turned lower after a mixed payrolls report showed the economy added fewer-than-expected jobs last month.Yields had climbed in recent days amid growing optimism about the economic outlook. Thursday's report had its bright spots, with the unemployment rate dropping…
dow-jones
USDA Exp Sales: Wheat 26-27 Net 300,100 Tons
USDA Exp Sales: Wheat 26-27 Net 300,100 Tons
dow-jones
U.S. Jobless Claims Fell Last Week
By Jessica CoacciU.S. jobless claims fell slightly last week, as firms continued to hold back from widespread layoffs.The number of people who filed for unemployment benefits was 215,000 in the week through June 27, versus the 216,000 reported a week earlier, the Labor Department said Thursday. Eco…
dow-jones
Absci Is Maintained at Buy by Truist Securities
(12:43 GMT) Absci Price Target Raised to $17.00/Share From $11.00 by Truist Securities
dow-jones
USDA Exp Sales:Soybeans 25-26 Net 41,800 Tons; 26-27 182,500
USDA Exp Sales:Soybeans 25-26 Net 41,800 Tons; 26-27 182,500
dow-jones
USDA Exp Sales: Corn 25-26 Net 732,100 Tons; 26-27 767,800
USDA Exp Sales: Corn 25-26 Net 732,100 Tons; 26-27 767,800
NEWS dow-jones
USDA Exp Sales: Cotton 25-26 Net 49,000 Bales; 26-27 44,100
USDA Exp Sales: Cotton 25-26 Net 49,000 Bales; 26-27 44,100
dow-jones
Revolution Medicines Advances Zoldonrasib to Phase 3 After Strong Pancreatic Cancer Trial Results
By Adriano MarcheseRevolution Medicines reported early trial results showed that its experimental drug zoldonrasib produced strong antitumor activity in two combination regimens for patients with metastatic pancreatic cancer.The late-stage clinical oncology company said Thursday that its drug zoldo…
dow-jones
Amass Brands Initiated at Buy by Maxim Group
(12:39 GMT) Amass Brands Price Target Announced at $7.00/Share by Maxim Group
dow-jones
Boliden: No Certainty a Transaction Will Take Place, Nor What Terms of Any Such Deal Would Be
Boliden: No Certainty a Transaction Will Take Place, Nor What Terms of Any Such Deal Would Be
dow-jones
Boliden in Talks With Nexa Resources and Votorantim Over Potential Buy of Votorantim's Shares in Nexa Resources
Boliden in Talks With Nexa Resources and Votorantim Over Potential Buy of Votorantim's Shares in Nexa Resources
ClearOne to Merge With Vivani Medical Subsidiary Cortigent
By Kelly CloonanClearOne plans to merge with Vivani Medical's brain implant device subsidiary Cortigent.Under the deal, Vivani would receive 12.5 million shares of ClearOne common stock as consideration for all of the issued and outstanding shares of Cortigent, giving it a stake in the combined com…
dow-jones
Coherent Is Maintained at Strong Buy by Raymond James
(12:35 GMT) Coherent Price Target Raised to $435.00/Share From $371.00 by Raymond James
dow-jones
GE Aerospace Is Maintained at Buy by Jefferies
(12:35 GMT) GE Aerospace Price Target Raised to $455.00/Share From $365.00 by Jefferies
dow-jones
Advisory: Chevron Corporation's 2Q 2026 Earnings Conference Call and Webcast
HOUSTON--(BUSINESS WIRE)--July 02, 2026--Chevron Corporation NYSE:CVX, one of the world's leading energy companies, will hold its quarterly earnings conference call on Friday, July 31, 2026 at 11:00 a.m. ET (10:00 a.m. CT).Conference Call Information:Date: Friday, July 31, 2026Time: 11:00 a.m. ET…
dow-jones
Ameris Bancorp to Announce Second Quarter 2026 Earnings on July 23, 2026
ATLANTA--(BUSINESS WIRE)--July 02, 2026--Ameris Bancorp NYSE:ABCB (the "Company") announced today that it intends to release its second quarter 2026 financial results in a press release after the market closes on Thursday, July 23, 2026. H. Palmer Proctor, Jr., Chief Executive Officer, Nicole S. St…
dow-jones
Rivian Releases Q2 2026 Production and Delivery Figures, Raises Full Year Delivery Outlook and Sets Date for Second Quarter 2026 Financial Results
(12:30 GMT) *Rivian Automotive Produced 12,613 Vehicles at Its Manufacturing Facility in Normal, Illinois in 2Q >RIVN (12:30 GMT) *Rivian Automotive Delivered 12,194 Vehicles During 2Q >RIVN (12:31 GMT) *Rivian Automotive Is Today Raising Its Full Yr 2026 Delivery Guidance From 62,000 - 67,000 Vehi…
dow-jones
Knight-Swift Transport Is Maintained at Strong Buy by Raymond James
(12:33 GMT) Knight-Swift Transport Price Target Raised to $91.00/Share From $76.00 by Raymond James